We are live on ! Find out more
RE

RBC Europe Portfolio holdings

AUM $2.08B
1-Year Est. Return 12.2%
This Fund
S&P 500
This Quarter Est. Return
+5.62%
1 Year Est. Return
-12.2%
3 Year Est. Return
+59.81%
5 Year Est. Return
+127.03%
10 Year Est. Return
AUM
$852M
AUM Growth
+$34.2M
Cap. Flow
-$2.21M
Cap. Flow %
-0.26%
Top 10 Hldgs %
41.05%
Holding
1,206
New
80
Increased
123
Reduced
188
Closed
61

Top Sells

Rank Stock Value
1
CELG
Celgene Corp
CELG
+$4.54M
2
KDP icon
Keurig Dr Pepper
KDP
+$3.78M
3
MON
Monsanto Co
MON
+$1.55M
4
VZ icon
Verizon
VZ
+$1.04M
5
PM icon
Philip Morris
PM
+$809K

Sector Composition

Rank Sector Weight
1 Financials 22.14%
2 Consumer Discretionary 16.55%
3 Technology 16.32%
4 Communication Services 12.04%
5 Healthcare 9.31%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DEO icon
526
Diageo
DEO
$51.7B
$38.2K ﹤0.01%
265
PX
527
DELISTED
Praxair Inc
PX
$38K ﹤0.01%
240
IDTI
528
DELISTED
Integrated Device Technology I
IDTI
$37.9K ﹤0.01%
1,190
LGND icon
529
Ligand Pharmaceuticals
LGND
$5.59B
$37.9K ﹤0.01%
293
-2
-0.7% -$223
ADI icon
530
Analog Devices
ADI
$175B
$37.9K ﹤0.01%
395
TLND
531
DELISTED
Talend S.A. American Depositary Shares
TLND
$37.4K ﹤0.01%
600
VWO icon
532
Vanguard FTSE Emerging Markets ETF
VWO
$127B
$36.7K ﹤0.01%
870
-720
-45% -$32.5K
MDCO
533
DELISTED
Medicines Co
MDCO
$36.7K ﹤0.01%
1,000
PRSP
534
DELISTED
Perspecta Inc. Common Stock
PRSP
$36.6K ﹤0.01%
+1,781
New +$39.9K
AFL icon
535
Aflac
AFL
$58.4B
$36.6K ﹤0.01%
850
CRTO icon
536
Criteo S.A.
CRTO
$855M
$36.6K ﹤0.01%
1,113
PARA
537
DELISTED
Paramount Global Class B
PARA
$36.5K ﹤0.01%
650
-100
-13% -$5.22K
VYX icon
538
NCR Voyix
VYX
$1.21B
$36.3K ﹤0.01%
1,972
ESV
539
DELISTED
Ensco Rowan plc
ESV
$36K ﹤0.01%
1,241
EIRL icon
540
iShares MSCI Ireland ETF
EIRL
$78.7M
$36K ﹤0.01%
760
IYE icon
541
iShares US Energy ETF
IYE
$1.83B
$35.6K ﹤0.01%
850
AMJ
542
DELISTED
JP Morgan Alerian MLP Index ETN 5/24/24
AMJ
$35.6K ﹤0.01%
1,340
-145
-10% -$3.79K
NTCT icon
543
NETSCOUT
NTCT
$2.84B
$35.6K ﹤0.01%
1,197
OR icon
544
OR Royalties Inc
OR
$7.01B
$35.5K ﹤0.01%
3,751
INFN
545
DELISTED
Infinera Corporation Common Stock
INFN
$35.4K ﹤0.01%
3,564
CBOE icon
546
Cboe Global Markets
CBOE
$32.4B
$35.4K ﹤0.01%
340
RAMP icon
547
LiveRamp
RAMP
$2.29B
$35.3K ﹤0.01%
1,180
SAIC icon
548
Saic
SAIC
$5.33B
$34.8K ﹤0.01%
430
M icon
549
Macy's
M
$5.79B
$34.3K ﹤0.01%
917
-475
-34% -$15.9K
WLY icon
550
John Wiley & Sons Class A
WLY
$2.73B
$34.3K ﹤0.01%
550

Similar funds

RBC Europe's Q2 2018 Portfolio in Review

As of Q2 2018, RBC Europe held 1,206 positions worth $852M, up 4.2% from $817M the previous quarter. Its ten largest holdings account for 41% of the portfolio.

RBC Europe's Q2 2018 filing shows 80 new, 123 increased, 188 reduced and 61 closed positions. Its largest new stake was Pluralsight, Inc. Class A Common Stock: 12,370 shares worth $302K. The largest sale was Celgene Corp, an estimated $4.54M.

By sector, the portfolio is most concentrated in Financials at 22% of assets, down from 23% a quarter earlier, followed by Consumer Discretionary and Technology.

  • RBC Europe's largest Q2 2018 buy was Pluralsight, Inc. Class A Common Stock: 12,370 shares worth $302K.
  • RBC Europe added most to Berkshire Hathaway Class B in Q2 2018, an estimated $4.02M increase.
  • RBC Europe's biggest Q2 2018 reduction was Celgene Corp, cutting an estimated $4.54M.
  • RBC Europe fully exited Monsanto Co in Q2 2018, selling an estimated $1.55M.
  • RBC Europe's ten largest holdings make up 41% of its $852M portfolio in Q2 2018.
  • RBC Europe opened 80 new positions and closed 61 in Q2 2018.
  • RBC Europe's portfolio value rose 4.2% quarter-over-quarter to $852M.

Based on RBC Europe's 13F filing for Q2 2018, filed 9 Nov 2023.